A new study found glucocorticoid therapy can reduce the amount of citrullination, a process that converts the protein building block arginine into citrulline, which is thought to increase inflammation, in the joints of people with rheumatoid arthritis, according to findings published in Arthritis Research & Therapy.

Researchers found the benefits of muscle relaxants and neuromodulators for treating rheumatoid arthritis pain don't outweigh the side effects, according to a news release.